Occurrence of psychotic symptoms during treatment of ADHD with methylphenidate: Clinical significance and the need for further research.
作者信息
Reiersen Angela M
出版信息
Scand J Child Adolesc Psychiatr Psychol. 2018 Jul 10;6(1):1-3. doi: 10.21307/sjcapp-2018-007. eCollection 2018.
Abstract
摘要
相似文献
1
Occurrence of psychotic symptoms during treatment of ADHD with methylphenidate: Clinical significance and the need for further research.使用哌醋甲酯治疗注意缺陷多动障碍（ADHD）期间出现的精神病性症状：临床意义及进一步研究的必要性。
Scand J Child Adolesc Psychiatr Psychol. 2018 Jul 10;6(1):1-3. doi: 10.21307/sjcapp-2018-007. eCollection 2018.
2
Hallucinations and other psychotic symptoms in response to methylphenidate in children and adolescents with attention-deficit/hyperactivity disorder: a Cochrane systematic review with meta-analysis and trial sequential analysis.注意缺陷多动障碍儿童和青少年使用哌甲酯后出现的幻觉及其他精神病性症状：一项Cochrane系统评价，包括荟萃分析和试验序贯分析
Scand J Child Adolesc Psychiatr Psychol. 2018 Jul 10;6(1):52-71. doi: 10.21307/sjcapp-2018-003. eCollection 2018.
3
[ADHD during childhood and subsequent psychotic disorder: A link?].[儿童期注意力缺陷多动障碍与后续精神障碍：存在关联？]
Encephale. 2021 Oct;47(5):484-490. doi: 10.1016/j.encep.2021.01.008. Epub 2021 May 13.
4
Methylphenidate-Induced Psychotic Symptoms in 65-Year-Old Female with ADHD.哌甲酯致65岁患注意缺陷多动障碍女性出现精神病性症状
Iran J Psychiatry. 2018 Oct;13(4):310-313.
5
Attention-deficit/hyperactivity disorder, methylphenidate use and the risk of developing schizophrenia spectrum disorders: A nationwide population-based study in Taiwan.注意力缺陷多动障碍、哌甲酯使用与精神分裂症谱系障碍的发病风险：一项基于台湾全国人口的研究
Schizophr Res. 2015 Oct;168(1-2):161-7. doi: 10.1016/j.schres.2015.08.033. Epub 2015 Sep 10.
6
Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.即刻释放型哌甲酯治疗成人注意缺陷多动障碍（ADHD）。
Cochrane Database Syst Rev. 2021 Jan 18;1(1):CD013011. doi: 10.1002/14651858.CD013011.pub2.
7
The Risk of Methylphenidate Pharmacotherapy for Adults with ADHD.成人注意力缺陷多动障碍使用哌甲酯药物治疗的风险
Pharmaceuticals (Basel). 2023 Sep 13;16(9):1292. doi: 10.3390/ph16091292.
8
Methylphenidate treatment for attention-deficit/hyperactivity disorder in children and adolescents with velocardiofacial syndrome: an open-label study.哌甲酯治疗患有心脏颜面综合征的儿童和青少年注意力缺陷/多动障碍：一项开放标签研究。
J Clin Psychiatry. 2003 Oct;64(10):1163-9. doi: 10.4088/jcp.v64n1004.
9
Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.速释型哌甲酯用于治疗成人注意力缺陷多动障碍（ADHD）
Cochrane Database Syst Rev. 2014 Sep 18(9):CD005041. doi: 10.1002/14651858.CD005041.pub2.
10
Treatment discontinuation with methylphenidate in adults with attention deficit hyperactivity disorder: a meta-analysis of randomized clinical trials.治疗成人注意缺陷多动障碍的哌醋甲酯停药：随机临床试验的荟萃分析。
Eur J Clin Pharmacol. 2013 Mar;69(3):347-56. doi: 10.1007/s00228-012-1390-7. Epub 2012 Sep 16.
引用本文的文献
1
Adverse Effects of Stimulant Interventions for Attention Deficit Hyperactivity Disorder (ADHD): A Comprehensive Systematic Review.注意力缺陷多动障碍（ADHD）刺激干预的不良反应：一项全面的系统评价
Cureus. 2023 Sep 26;15(9):e45995. doi: 10.7759/cureus.45995. eCollection 2023 Sep.
本文引用的文献
1
Hallucinations and other psychotic symptoms in response to methylphenidate in children and adolescents with attention-deficit/hyperactivity disorder: a Cochrane systematic review with meta-analysis and trial sequential analysis.注意缺陷多动障碍儿童和青少年使用哌甲酯后出现的幻觉及其他精神病性症状：一项Cochrane系统评价，包括荟萃分析和试验序贯分析
Scand J Child Adolesc Psychiatr Psychol. 2018 Jul 10;6(1):52-71. doi: 10.21307/sjcapp-2018-003. eCollection 2018.
2
Psychopathology in 7-year-old children with familial high risk of developing schizophrenia spectrum psychosis or bipolar disorder - The Danish High Risk and Resilience Study - VIA 7, a population-based cohort study.有精神分裂症谱系精神病或双相情感障碍家族高风险的7岁儿童的精神病理学——丹麦高风险与复原力研究——VIA 7，一项基于人群的队列研究。
World Psychiatry. 2018 Jun;17(2):210-219. doi: 10.1002/wps.20527.
3
Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.用于治疗儿童和青少年注意力缺陷多动障碍（ADHD）的哌甲酯——非随机研究中不良事件的评估
Cochrane Database Syst Rev. 2018 May 9;5(5):CD012069. doi: 10.1002/14651858.CD012069.pub2.
4
Pharmacogenetics predictors of methylphenidate efficacy in childhood ADHD.儿童注意缺陷多动障碍中哌甲酯疗效的药物遗传学预测因子。
Mol Psychiatry. 2018 Sep;23(9):1929-1936. doi: 10.1038/mp.2017.234. Epub 2017 Dec 12.
5
Genetic Overlap Between Schizophrenia and Developmental Psychopathology: Longitudinal and Multivariate Polygenic Risk Prediction of Common Psychiatric Traits During Development.精神分裂症与发育心理病理学的遗传重叠：常见精神疾病特征在发展过程中的纵向和多变量多基因风险预测。
Schizophr Bull. 2017 Oct 21;43(6):1197-1207. doi: 10.1093/schbul/sbx031.
6
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).用于治疗儿童和青少年注意力缺陷多动障碍（ADHD）的哌甲酯。
Cochrane Database Syst Rev. 2015 Nov 25;2015(11):CD009885. doi: 10.1002/14651858.CD009885.pub2.
7
Prescription stimulant use is associated with earlier onset of psychosis.使用处方兴奋剂与精神病的更早发作有关。
J Psychiatr Res. 2015 Dec;71:41-7. doi: 10.1016/j.jpsychires.2015.09.012. Epub 2015 Sep 21.
8
Risk of bipolar disorder and schizophrenia in relatives of people with attention-deficit hyperactivity disorder.注意缺陷多动障碍患者亲属的双相情感障碍和精神分裂症风险。
Br J Psychiatry. 2013 Aug;203(2):103-6. doi: 10.1192/bjp.bp.112.120808. Epub 2013 May 23.
9
Static and dynamic cognitive deficits in childhood preceding adult schizophrenia: a 30-year study.儿童期静态和动态认知缺陷与成年精神分裂症的关系：一项 30 年的研究。
Am J Psychiatry. 2010 Feb;167(2):160-9. doi: 10.1176/appi.ajp.2009.09040574. Epub 2010 Jan 4.
Zotero 插件